Drugs that contain Levothyroxine Sodium
1. Ermeza patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9345772 | MYLAN | Liquid levothyroxine formulations |
Feb, 2035
(10 years from now) | |
Market Authorisation Date: 29 April, 2022
Treatment: NA
Dosage: SOLUTION;ORAL
More Information on Dosage
ERMEZA family patents
2. Levo-t patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6399101 | CEDIPROF INC | Stable thyroid hormone preparations and method of making same |
Mar, 2020
(4 years ago) | |
Market Authorisation Date: 01 March, 2002
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
LEVO-T family patents
3. Levolet patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10231931 | GENUS LIFESCIENCES | Thyroid hormone oral dosage forms and methods of using the same |
Mar, 2038
(13 years from now) | |
| US10406108 | GENUS LIFESCIENCES | Thyroid hormone oral dosage forms and methods of using the same |
Mar, 2038
(13 years from now) | |
Market Authorisation Date: 06 June, 2003
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
LEVOLET family patents
4. Levothyroxine Sodium patents expiration
LEVOTHYROXINE SODIUM Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9168239 | FRESENIUS KABI USA | Levothyroxine formulations |
Aug, 2032
(8 years from now) | |
| US9168238 | FRESENIUS KABI USA | Levothyroxine formulations |
Aug, 2032
(8 years from now) | |
| US9006289 | FRESENIUS KABI USA | Levothyroxine formulations |
Oct, 2032
(8 years from now) | |
| US10398669 | FRESENIUS KABI USA | Levothyroxine liquid formulations |
Dec, 2036
(12 years from now) | |
| US11135190 | FRESENIUS KABI USA | Levothyroxine liquid formulations |
Dec, 2036
(12 years from now) | |
| US9782376 | FRESENIUS KABI USA | Levothyroxine liquid formulations |
Dec, 2036
(12 years from now) | |
Market Authorisation Date: 24 June, 2011
Treatment: NA
Dosage: POWDER;INTRAVENOUS; SOLUTION;INTRAVENOUS
How can I launch a generic of LEVOTHYROXINE SODIUM before it's drug patent expiration?
More Information on Dosage
LEVOTHYROXINE SODIUM family patents
5. Levothyroxine Sodium patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11154498 | HIKMA | Stabilized liquid formulation of levothyroxine |
Jul, 2036
(12 years from now) | |
Market Authorisation Date: 17 May, 2021
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
How can I launch a generic of LEVOTHYROXINE SODIUM before it's drug patent expiration?
More Information on Dosage
LEVOTHYROXINE SODIUM family patents
6. Levoxyl patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7067148 | KING PHARMS | Stabilized pharmaceutical and thyroid hormone compositions and method of preparation |
Feb, 2022
(2 years ago) | |
| US6555581 | KING PHARMS | Levothyroxine compositions and methods |
Feb, 2022
(2 years ago) | |
| US7101569 | KING PHARMS | Methods of administering levothyroxine pharmaceutical compositions |
Oct, 2023
(6 months ago) | |
Market Authorisation Date: 25 May, 2001
Treatment: Method of use of administering levothyroxine
Dosage: TABLET;ORAL
How can I launch a generic of LEVOXYL before it's drug patent expiration?
More Information on Dosage
LEVOXYL family patents
7. Thyquidity patents expiration
THYQUIDITY's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9050307 | AZURITY | Method for the preparation of a levothyroxine solution |
Aug, 2031
(7 years from now) | |
Market Authorisation Date: 30 November, 2020
Treatment: NA
Dosage: SOLUTION;ORAL
How can I launch a generic of THYQUIDITY before it's drug patent expiration?
More Information on Dosage
THYQUIDITY family patents
8. Tirosint patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7691411 | IBSA | Pharmaceutical formulae for thyroid hormones and procedures for obtaining them |
Mar, 2024
(a month ago) | |
| US7723390 | IBSA | Pharmaceutical formulations for thyroid hormones |
Mar, 2024
(a month ago) | |
Market Authorisation Date: 02 October, 2009
Treatment: NA
Dosage: CAPSULE;ORAL
How can I launch a generic of TIROSINT before it's drug patent expiration?
More Information on Dosage
TIROSINT family patents
9. Tirosint patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7723390 | INSTITUT BIOCHIMIQUE | Pharmaceutical formulations for thyroid hormones |
Mar, 2024
(a month ago) | |
Market Authorisation Date: 01 August, 2007
Treatment: NA
Dosage: CAPSULE;ORAL
How can I launch a generic of TIROSINT before it's drug patent expiration?
More Information on Dosage
TIROSINT family patents
10. Tirosint-sol patents expiration
TIROSINT-SOL's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10537538 | IBSA | High-stability packaged solutions of T4 thyroid hormone |
Feb, 2037
(12 years from now) | |
| US11096913 | IBSA | High-stability packaged solutions of T4 thyroid hormone |
Feb, 2037
(12 years from now) | |
| US11241382 | IBSA | Administration regimen of compositions of T4 thyroid hormone with high oral absorption |
Sep, 2039
(15 years from now) | |
Market Authorisation Date: 13 January, 2021
Treatment: Treatment of hypothyroidism by oral administration of l-thyroxine to a patient on an empty stomach 15 minutes before breakfast
Dosage: SOLUTION;ORAL
How can I launch a generic of TIROSINT-SOL before it's drug patent expiration?
More Information on Dosage
TIROSINT-SOL family patents